
relatively selective fatty acid amide hydrolase (FAAH) inhibitor with IC50 and intact neurons, respectively. FAAH is the primary degradatory anandamide and, as such, inhibition of FAAH leads to an CNS and periphery where it activates cannabinoid receptors. URB597 and analgesic effects by increasing endocannabinoids. and anxiolytic effects in vivo but not evokes other symptoms